Jane Visvader
Jane Visvader | |
|---|---|
 | |
| Alma mater | University of Adelaide |
| Scientific career | |
| Institutions | Walter and Eliza Hall Institute of Medical Research Salk Institute |
Jane Visvader FRS FAA FAHMS is a scientist specialising in breast cancer research who works for the Walter and Eliza Hall Institute in Melbourne, Australia. She is the joint head of the Breast Cancer Laboratory with Geoff Lindeman.[1] In 2008, Visvader was a joint recipient of the GlaxoSmithKline Award for Research Excellence[2] for outstanding contribution to Breast Cancer research. Visvader was made a fellow of the Australian Academy of Science in 2012.[3] Her most recent award is the 2014 Royal Society of Victoria Research Medal for Scientific Excellence in Biomedical & Health Sciences.[4]
Education
Visvader holds a PhD in Biochemistry from the University of Adelaide having studied structure and function of citrus exocortis viroid[5]
Career and research
After her PhD, she was a postdoctoral researcher the Verma Laboratory (Salk Institute, San Diego) and Adams Laboratory (Walter and Eliza Hall Institute (WEHI)).[citation needed] She worked at the Children's Hospital/Harvard Medical School in Boston before returning to Victoria in 1997 to establish a Breast Cancer Laboratory at WEHI.[6] She was awarded a fellowship of the Australian Academy of Health and Medical Sciences in October 2016.[7]
Visvader has published work investigating the role of cells of origin in cancer[8] and in particular focuses on the role of stem cells,[9][10] which she believes may be a key to understanding breast cancer.[11]
Patents
Visvader is a named inventor on five patents relating to cancer research focused on stem cell isolation and diagnostics.[12]
- Method Of Cell Isolation, Application number: 20080038230
- Differentiation and/or proliferation modulating agents and uses therefor, Application number: 20060166917
- Novel phosphoprotein, Application number: 20060148032
- Method of diagnosis and treatment and agents useful for same, Application number: 20050048528
- Differentiation and/or proliferation modulating agents and uses therefor, Application number: 20030175971
References
- ^ "Professor Jane Visvader". Retrieved 2014-08-14.
- ^ "Latest News - Walter and Eliza Hall Institute of Medical Research". Archived from the original on 2014-08-14. Retrieved 2014-08-14.
- ^ "Fellowship list - Australian Academy of Science". Science.org.au. Retrieved 2014-08-14.
- ^ "News | Royal Society of Victoria | Promoting Science and Science Education". Royalsocietyvictoria.org.au. Retrieved 2014-08-14.
- ^ "Structure and function of citrus exocortis viroid / by Jane Ellen Visvader. - Version details - Trove". Trove.nla.gov.au. 2006-12-28. Retrieved 2014-08-14.
- ^ "News | Royal Society of Victoria | Promoting Science and Science Education". Royalsocietyvictoria.org.au. Retrieved 2014-08-14.
- ^ "AAHMS announces its second scientific meeting and induction of new fellows" (PDF). Australian Academy of Health and Medical Sciences. Retrieved 14 October 2016.
- ^ Visvader, Jane E. (2011). "Cells of origin in cancer". Nature. 469 (7330): 314–322. doi:10.1038/nature09781. PMID 21248838.
- ^ Rios, Anne C.; Fu, Nai Yang; Lindeman, Geoffrey J.; Visvader, Jane E. (2014). "In situ identification of bipotent stem cells in the mammary gland". Nature. 506 (7488): 322–327. doi:10.1038/nature12948. PMID 24463516.
- ^ Visvader, Jane E.; Lindeman, Geoffrey J. (2012). "Cancer Stem Cells: Current Status and Evolving Complexities". Cell Stem Cell. 10 (6): 717–728. doi:10.1016/j.stem.2012.05.007. PMID 22704512.
- ^ Giovanni Valenti (2012-01-11). "Interview with Jane Visvader: stem cells in the breast | Europe's stem cell hub". Nature. 439 (7072): 84–88. doi:10.1038/nature04372. PMID 16397499. Retrieved 2014-08-14.
- ^ "Patents by Inventor Jane Visvader - Justia Patents Database". Patents.justia.com. Retrieved 2014-08-14.
| International | |
|---|---|
| National | |
| Academics | |
